Bendamustine as a model for the activity of alkylating agents

By Apostolopoulos Christos   Castellano Leandro   Stebbing Justin   Giamas Georgios  

Future Oncology, Vol. 4, Iss. 3, 2008-06 ,pp. : 323-332

Future Medicine

Access to resources Recommend Favorite

Design of Novel Antitumor DNA Alkylating Agents: The Benzacronycine Series

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 4, Iss. 2, 2004-03 ,pp. : 83-92

Bentham Science Publishers

Access to resources Recommend Favorite

A Short Review on the Synthetic Strategies of Duocarmycin Analogs that are Powerful DNA Alkylating Agents

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 15, Iss. 5, 2015-01 ,pp. : 616-630

Bentham Science Publishers

Access to resources Recommend Favorite

Use of tumor lines with selectable markers in assessing the effect on experimental metastases of combination chemotherapy with alkylating agents

By Miller B.E.   delmonico L.   Vistisen K.   Miller F.R.  

Clinical and Experimental Metastasis, Vol. 16, Iss. 5, 1997-07 ,pp. : 480-488

Springer Publishing Company

Access to resources Recommend Favorite

Interleukin-1α-induced Tumour Pathophysiologies Can Be Exploited with Bioreductive Alkylating Agents

By Braunschweiger P.G.   Jones S.A.   Johnson C.S.   Furmanski P.  

International Journal of Radiation Biology, Vol. 60, Iss. 1-2, 1991-07 ,pp. : 369-372

Informa Healthcare

Access to resources Recommend Favorite